Bales Brian A 4

What Happened Brian A. Bales, a director of RB Global Inc. (RBA), received four derivative awards on 2026-06-18 totaling 26 dividend-equivalent rights (7, 8, 5 and 6 units). Each grant is reported at $0.00 (no cash paid). These awards are derivative dividend-equivalent rights tied to deferred share units (DSUs) and restricted share units (RSUs), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-18; reported in Form 4 filed 2026-06-23 (appears filed 5 days after the transaction).
• Transaction type/code: A = Award/Grant; treated as derivative instruments (dividend-equivalent rights).
• Quantity and prices: 7, 8, 5 and 6 units (26 total) at $0.00 each.
• Shares/units owned after transaction: Not disclosed in this filing.
• Footnotes:
  • F1: Dividend equivalents on deferred share units (DSUs) payable/exercisable with the DSUs.
  • F2–F4: Dividend equivalents accrued on RSU grants from 2024–2026, exercisable proportionately with those RSUs.
  • All dividend-equivalent rights represent contingent rights to receive the economic equivalent of one RBA common share when payable.
• Timeliness: Form 4 was filed on 2026-06-23 for a 2026-06-18 transaction (appears late versus the typical Form 4 reporting window).

Context Dividend-equivalent rights are not immediate stock ownership; they mirror dividend value and become payable or convertible along with the underlying DSUs/RSUs as they vest or are paid out. Such awards are common components of director compensation and do not by themselves signal a purchase-driven bullish vote. The filing provides detail on the nature of the derivative awards but does not disclose total post-transaction holdings.